← Back to guidelines
Cardiology39 papers

Pleural empyema with fistula

Last edited: 4/15/2026

Overview

Pleural empyema with fistula involves a severe, infected pleural space often complicating parapneumonic effusions, characterized by loculations and potential communication with deeper structures or skin. 1

Diagnosis

  • Clinical Presentation: Fever, dyspnea, chest pain, and signs of systemic infection.
  • Imaging: Chest CT or ultrasound showing loculated fluid, air-fluid levels, and possible fistulae.
  • Laboratory Tests: Elevated inflammatory markers (CRP, ESR).
  • Fluid Analysis: Pleural fluid pH < 7.2, LDH/CR ratio > 0.6, and positive Gram stain/culture.
  • Bacterial Etiology: Identification of causative organisms via pleural fluid cultures; pneumococcal decline noted post-PCV13 implementation. 1
  • Management

  • Antibiotics: Initial broad-spectrum coverage followed by targeted therapy based on culture results.
  • Pleural Drainage: Indicated for loculated effusions; chest tube or image-guided procedures.
  • Decortication: Surgical intervention for refractory cases with extensive pleural thickening.
  • Fistula Management: Surgical repair or endoscopic interventions for persistent fistulae.
  • Supportive Care: Oxygen, fluid management, and monitoring for complications.
  • Special Populations

  • Pediatrics: Post-PCV13 implementation, group A streptococcus is increasingly recognized as a leading cause of empyema 1.
  • Key Recommendations

  • Implement targeted antibiotic therapy based on pleural fluid culture results (Evidence: Strong 1).
  • Use imaging (CT/ultrasound) to guide management decisions in pleural empyema with suspected fistulae (Evidence: Moderate 1).
  • Consider surgical decortication for patients with persistent loculations unresponsive to medical management (Evidence: Moderate 1).
  • References

    1 Madhi F, Levy C, Morin L, Minodier P, Dubos F, Zenkhri F et al.. Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation. Journal of the Pediatric Infectious Diseases Society 2019. link

    Original source

    1. [1]
      Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation.Madhi F, Levy C, Morin L, Minodier P, Dubos F, Zenkhri F et al. Journal of the Pediatric Infectious Diseases Society (2019)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG